THE OVERARCHING OBJECTIVE IS TO ESTABLISH A QUANTITATIVE IN VITRO IN VIVO EXTRAPOLATION FRAMEWORK CAPABLE OF PREDICTING THE INFLUENCE OF FORMULATION COMPOSITION, DIGESTION BEHAVIOR, CHYLOMICRON BINDING, AND PRANDIAL STATE ON DRUG BIOAVAILABILITY AND
$651,399
| Recipient | SIMULATIONS PLUS INC UEI MZN6WDBMXN24 |
|---|---|
| Award ID | 75F40126C00063 |
| Award amount | $651,399 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — Food and Drug Administration |
| NAICS | 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) |
| PSC | AN21 |
| Set-aside | Unrestricted |
| Start date | Sep 30, 2026 |
| End date | Dec 29, 2027 |
| Place of performance | SILVER SPRING, MD |
| Record updated | Sep 28, 2026 |
View the official award record
More awards won by SIMULATIONS PLUS INC
GASTROPLUS?, DDDPLUS AND MEMBRANEPLUS SOFTWARE LICENSES
Department of Health and Human Services · $375,965 · Aug 31, 2021
Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.
Search open bids